High CD4 count before HIV treatment contributes to smaller HIV reservoir on ART
Researchers found that people infected with HIV who maintained a CD4+ count during untreated infection as high as that in
CD4 T Cells
Rousing the reservoir: understanding more about where HIV hides in lymph nodes
Sydney researchers are leading a study to discover more about the HIV reservoir. The TRESAX study seeks to find out
CRISPR CCR5 edits safe but limited
Chinese scientists used CRISPR gene editing to alter CCR5 in stem cells from a 27 year old male. The edited
New clue about HIV latency maintenance
Yale researchers have highlighted the role of APOBEC3A (A3A) in sustaining HIV latency. A3A is typically found in immune cells
What’s the fuss about a functional cure?
A recent study from researchers in Hong Kong has got the world’s media talking about a functional cure for HIV. A
Doing FLIPS: a new way to find latent HIV
Researchers have revealed a new way to understand the HIV that stays in the body during therapy. The group from
Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells
Highlights The mode of HIV-1 spread determines the outcome form of cell death Cell-to-cell spread is required to deplete non-permissive
Have we been looking for HIV in all the wrong places?
Have researchers and doctors been looking for HIV in all the wrong places? That’s what the scientists involved in the
The cure: are we any closer?
These days, most PLHIV are able to achieve an undetectable viral load within three months of starting treatment and to sustain that level indefinitely.